Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review

Source: Nasdaq GlobeNewswire / 25 May 2023 19:00:54   America/New_York